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Abstract
The human small intestinal epithelium possesses a distinct crypt-villus architecture and tissue 
polarity in which proliferative cells reside inside crypts while differentiated cells are localized to 
the villi. Indirect evidence has shown that the processes of differentiation and migration are driven 
in part by biochemical gradients of factors that specify the polarity of these cellular compartments; 
however, direct evidence for gradient-driven patterning of this in vivo architecture has been 
hampered by limitations of the in vitro systems available. Enteroid cultures are a powerful in vitro 
system; nevertheless, these spheroidal structures fail to replicate the architecture and lineage 
compartmentalization found in vivo, and are not easily subjected to gradients of growth factors. In 
the current work, we report the development of a micropatterned collagen scaffold with suitable 
extracellular matrix and stiffness to generate an in vitro self-renewing human small intestinal 
epithelium that replicates key features of the in vivo small intestine: a crypt-villus architecture 
with appropriate cell-lineage compartmentalization and an open and accessible luminal surface. 
Chemical gradients applied to the crypt-villus axis promoted the creation of a stem/progenitor-cell 
zone and supported cell migration along the crypt-villus axis. This new approach combining 
microengineered scaffolds, biophysical cues and chemical gradients to control the intestinal 
epithelium ex vivo can serve as a physiologically relevant mimic of the human small intestinal 
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epithelium, and is broadly applicable to model other tissues that rely on gradients for physiological 
function.
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1. Introduction
The small intestine is a highly specialized organ that is the major site for digestion and 
nutrient absorption as well as serving critical roles in oral drug uptake and metabolism, 
while also being a target of many pathogens and toxins [1]. The lining of the small intestine 
is a monolayer composed primarily of absorptive enterocytes that are arranged along a 
microscale topography [2] composed of tightly spaced invaginations (crypts) that are 
contiguous with larger projections into the intestinal lumen (villi). Stem cells reside in the 
crypts and proliferate to give rise to differentiated cells that migrate up the crypt-villus axis 
and cover the villi projections [3]. The microenvironment of the crypt-villus axis, 
particularly the presence of chemical gradients of growth and morphogens, is believed to 
play an important role in patterning the polarity of proliferative and differentiated 
compartments and regulation of proper stem/progenitor cell differentiation of the small 
intestinal epithelium [4]. It has also been recognized that metabolic factors generated by the 
gut microbiome form gradients from the lumen to crypt that likely impact development, 
health and disease of the intestine as well as the organism as a whole [5–8]. Despite a wealth 
of indirect evidence, the detailed role of various chemical factors and their concentrations 
within the crypt-villus microenvironment remains poorly understood [9]. Experimental 
modeling of intestinal epithelial biology and physiology are limited due to the lack of ex 
vivo platforms that mimic key features of the small intestinal epithelium such as distinct 
stem/progenitor and differentiated cell compartments, forward and reverse gradients of 
mitogens/morphogens and nutrients, and ordered cellular migration along the crypt-villus 
axis [10].
Prior to the current age of organoid (or enteroid) technologies [11], ex vivo small intestine 
models were relegated to the use of colon cancer cell lines as no reliable small intestinal 
transformed cell line exits. With the goal of developing a miniaturized in vitro assay 
platform having the potential to replicate small intestinal form and function, a number of 
microdevices have been developed, almost all of which incorporate the Caco-2 cancer cell 
line as the tissue mimic [2, 10, 12–26]. These devices use a variety of techniques to create a 
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topological representation of the microenvironment. Microscale 3D scaffolds and surface 
coatings employing extracellular matrices (ECM) have been shown to influence growth 
properties, differentiation, gene expression and absorptive functions of Caco-2 cells cultured 
on these devices [2, 12, 13, 19, 21]. To better replicate biomimetic surface properties, a 
number of different materials have been incorporated into the devices as substrates for cell 
culture, including hydrogels, PDMS, silk and decellularized porcine intestine [12, 17, 20, 
22]. The introduction of dynamic properties such as fluid-flow-induced shear stress and 
cyclic mechanical strain have also been shown to impact the physiological properties of the 
Caco-2 cells within a microenvironment [14, 15, 18, 23–25]. Co-culture of the Caco-2 cells 
with other cell types impacts the differentiation and function of these tumor cells [20, 26]. 
However, it is well-recognized that tissue-cultured cells derived from colon tumors fail to 
recapitulate normal small intestine cell lineages and function [27, 28]. Cancer cell lines 
harbor other features including accelerated accumulation of genetic mutations, loss of 
normal physiologic responses, and adaptations to tissue-cultured growth, e.g. the ability to 
grow in the absence of an ECM, that render them imperfect compared to primary tissue 
cultures [27–30]. Despite these drawbacks, use of cancer cells dominates microdevice 
development since native intestinal tissue quickly undergoes differentiation and/or apoptosis 
when cultured on non-biological surfaces [31–33].
Fortuitously, innovations in intestinal stem-cell culture methods have made it possible to use 
primary, non-transformed cells to create specialized tissues in vitro [34, 35]. With these 
methods, primary animal and human intestinal stem cells can be used to create multi-cellular 
structures known as enteroids that mimic many of the aspects of the small intestinal 
epithelium [11, 36]. The potential for intestinal enteroid technology is enormous as 
evidenced by the burgeoning number of reports and reviews on the topic [36–38]. 
Nevertheless, the cystic, spherical architecture of enteroids presents severe limitations in 
many applications. Current culture systems yield an enteroid with an enclosed lumen buried 
within a thick mass of Matrigel (a hydrogel) [39]. The luminal aspect of the enteroid is thus 
not easily accessed by drugs, toxins, probiotics, microbiota and other agents. Furthermore, 
culture of cells embedded within a hydrogel presents additional problems for assay 
development including the need for compounds to diffuse through the hydrogel to reach the 
enteroid, which may lead to artifacts during time sensitive assays, and the potential for 
dosage errors due to adsorption of the compound into the hydrogel. Thus, there is a pressing 
need for engineered culture systems to address the enteroid limitations by providing an 
accessible luminal surface for ready assay performance yet preserving the stem and 
differentiated cells present in the enteroids.
The combination of advances in the culture of primary stem cells and their differentiated 
progeny with cutting-edge microengineered systems now makes it possible to develop 
functional human intestinal epithelium on lab-on-chip devices [40, 41]. Critical to this 
endeavor are identification of a biomimetic material with appropriate ECMs and stiffness to 
support both stem and differentiated cells and to construct scaffolding of the proper 3D 
topography for crypts and villi. When this is combined with tightly controlled environments 
enabled by microscale devices, sustained, biochemical gradients should be capable of 
directing a polarized cellular architecture. In this manuscript, we describe our work to 
identify a cross-linked collagen hydrogel that permits stem cell maintenance and 
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proliferation as well as formation of the differentiated lineages of the small intestine. This 
hydrogel was then micromolded on a porous substrate in a 3D topography that recapitulated 
the crypt/villus architecture of the small intestinal epithelium. This human 3D tissue was 
then subjected to chemical gradients applied to the basal-luminal axis to create stem/
proliferative and differentiated cells zones, formation of appropriate differentiated lineages 
and cell movement along the crypt-villus axis analogous to that seen in vivo.
2. Experimental section
2.1. Materials
Matrigel, sodium bicarbonate, rat tail type I collagen, and Transwell inserts were purchased 
from Corning. N-acetyl cysteine was obtained from MP Bio. Murine EGF was from 
Peprotech. Primocin was from InvivoGen. Gastrin was from Anaspec. Nicotinamide, 
A83-01, sodium periodate, poly(ethylene glycol) methyl ether acrylate monomer, and benzyl 
alcohol were from Sigma Aldrich. Prostaglandin E2 (PGE2) was from Cayman Chemicals. 
SB202190 was from Selleckchem. Y-27632 was from ApexBio. Sodium butyrate was from 
Acros Organics. DAPT was from Xcessbio. Accutase was from STEMCELL Technologies. 
Collagenase (type IV) was from Worthington Biochemicals. Human collagen (type I) was 
obtained from Advanced Biomatrix. PTFE porous membrane was from Millipore. The 
biocompatible transfer adhesive was from 3M. Red alkaline phosphatase substrate kit was 
from Vector Labs. Antibodies and serum were purchased as follows: rabbit α-Muc2, integrin 
β4, villin, and ZO-1 were from Santa Cruz; mouse α-cytokeratin 20 (KRT20) was from 
ProteinTech; rabbit α-olfactomedin-4 (Olfm4) was from Cell Signaling; rabbit α-ezrin was 
from ThermoFisher; donkey serum and donkey anti-rabbit or mouse IgG conjugated with 
Alexa Fluor 488 were from Jackson Immunoresearch. Reveal Decloaker antigen retrieval 
solution was from Biocare Medical. All other reagents were from ThermoFisher Scientific.
2.3. Cell culture media
Medium for expanding stem/progenitor cells either as enteroids (embedding in Matrigel) or 
monolayers (on the surface of neutralized collagen hydrogel), termed expansion medium 
(EM), was prepared from a mixture of advanced DMEM/F12 medium, L-WRN conditioned 
medium, and supplemented with GlutaMAX (1×), B27 (1×), HEPES (10 mM), N-acetyl 
cysteine (1.25 mM), nicotinamide (10 mM), EGF (50 ng/mL), gastrin (10 nM), 
prostaglandin E2 (10 nM), SB202190 (3 μM), penicillin (100 unit/mL), streptomycin (100 
μg/mL), and primocin (100 μg/mL) [42]. L-WRN conditioned medium was prepared from 
L-WRN cells (ATCC #CRL-3276) following a published protocol [35]. This cell line 
produces Wnt-3A, R-spondin 3, and noggin. For the first 48 h after cell isolation or passage, 
Y-27632 ROCK inhibitor (10 μM) was added to the EM to block apoptosis. Stem medium 
(SM) was identical to EM, but the TGF β-inhibitor A83-01 (500 ng/mL) was added. 
Differentiation medium (DM) was identical to SM, but lacked L-WRN conditioned medium. 
The detailed information about reagents and media compositions is listed in Table S1 and 
S2.
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2.3. Isolation of crypts from human small intestinal surgical specimen
A surgical specimen of human small intestine (jejunum) was obtained from gastric bypass 
surgery at UNC Hospitals with consent of the patient (under the approved protocol UNC 
IRB #14-2013). Villi and crypts were detached from the specimen by incubation in a 
chelating buffer for 75 min at 20 °C followed by vigorous shaking in a 15-mL conical tube. 
The chelating buffer was composed of EDTA (2 mM), dithiothreitol (DTT, 0.5 mM, freshly 
added), Na2HPO4 (5.6 mM), KH2PO4 (8.0 mM), NaCl (96.2 mM), KCl (1.6 mM), sucrose 
(43.4 mM), D-sorbitol (54.9 mM), pH = 7.4 [43]. A few hundred crypts were obtained from 
the small clinical specimen. Released crypts were placed into either enteroid or monolayer 
culture systems less than 30 min after isolation.
2.4. Enteroid culture system based on Matrigel encapsulation
Isolated crypts were encapsulated in Matrigel for enteroid culture as described previously 
[35, 43]. Briefly, 1,000 crypts (admixed with villi) were suspended in 60 μL of cold Matrigel 
and then a 15 μL suspension was added to each well of a 24-well plate. After gelation of the 
Matrigel at 37 °C for 15 min, 500 μL of EM was added to each well. The EM was refreshed 
every 48 h. Every 4–5 days, the enteroids were dissociated with Accutase and passaged to a 
new 24-well plate at a ratio of 1:3.
2.5. Monolayer culture system on the surface of neutralized collagen hydrogel
Neutralized collagen hydrogel (1 mg/mL, pH 7.4, rat tail) was prepared in 6-well plates for 
the monolayer culture. Collagen (dissolved in 0.02 N acetic acid) was neutralized with 
sodium hydroxide (1.15 molar equivalent of acetic acid), HEPES (20 mM), sodium 
bicarbonate (53 mM), and phosphate-buffered saline (PBS, 1×) at 4 °C with a final pH of 7.4 
to generate a 1 mg/mL solution. 1 mL of the solution was added to each well of the 6-well 
plate and incubated at 37 °C for 1 h to generate a clear hydrogel. PBS was used to cover the 
hydrogel during storage. Before plating epithelial cells, the collagen hydrogel was rinsed 
with PBS for 5 min ×3. Enteroids were converted to monolayers by first extracting them 
from the Matrigel patty by pipetting the gel in buffer using a 200 μL pipet tip, dissociating 
them with Accutase, and then plated the cells on the top of a collagen hydrogel and cultured 
in EM. The EM was refreshed every 48 h. When the cell surface coverage was greater than 
70% (typically 5–7 days), the monolayers were passaged by a two-step dissociation method. 
In the first step, the monolayer was detached from the collagen hydrogel by scraping the 
collagen (with attached cells) from the well, and transferring the gel/cells to a 15-mL conical 
tube containing 1 mL EM with 500 U/mL of collagenase (Type IV, 500 U/mL). The gel was 
then fragmented into small pieces by repetitive pipetting. The suspension was then incubated 
at 37 °C for 10 min to completely digest the collagen gel. The monolayer fragments were 
pelleted by centrifugation at 600 × g for 1 min, rinsed with 5 mL PBS, and pelleted again. 
The second step was to break up the monolayer into small fragments by incubating the pellet 
in 150 μL PBS containing EDTA (0.5 mM) and Y-27632 (10 μM) at 37 °C for 5 min. The 
monolayers were repetitively pipetted to create smaller fragments. The cell fragments were 
re-suspended in EM and sub-cultured on a new collagen hydrogel at a passage ratio of 1:3. 
To ensure that the cells possessed normal chromosomes, cells were karyotyped 
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(KaryoLogic, Inc) at passage number P3 and P15. Twenty cells from each sample were 
analyzed. Cells were never used beyond P15.
2.6. Lineage differentiation
Lineage differentiation was performed using a method adapted from that published 
previously [44]. Cells were cultured as monolayers in EM for 4 days followed by moving 
the cells to DM to initiate cell differentiation. Sodium butyrate (abbreviated as “B”, 5 mM) 
or gamma-secretase inhibitor DAPT (abbreviated as “D”, 10 μM) was added as indicated.
2.7. Cross-linking collagen hydrogel by EDC/NHS chemistry
To improve the collagen integrity, collagen was cross-linked with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) 
at pH 5 [45]. Collagen solution (in 0.02 N acetic acid) was lyophilized for 72 h to remove 
water and acetic acid. The lyophilized collagen was dissolved in 2-(N-
morpholino)ethanesulfonic acid (MES) buffer (0.1 M, pH 5) at a concentration of 5 mg/mL. 
To prepare cross-linked collagen, 4 mg/mL collagen, 60 mM EDC and 15 mM NHS in MES 
buffer (0.1 M, pH 5) were mixed in a conical tube on ice. Air bubbles were removed by 
centrifugation at 3,000 × g for 1 min. 1 mL of the mixture was added to a well of a 6-well 
plate. After incubating the hydrogel at 22 °C for 60 min, the collagen scaffold was placed in 
copious deionized water for 24 h to remove excess EDC and NHS. The hydrogel was 
sterilized with 75% ethanol, rinsed with PBS ×5, and stored in PBS at 4 °C. The Young’s 
modulus of the cross-linked collagen was 9.5±0.6 KPa (n=3) measured by atomic force 
microscopy (MFP-3D, Asylum Research) by recording force versus indentation and fitting 
the curves to the Hertz model [46]. A polystyrene spherical tip (Novascan Technologies) 
with a radius of 2.25 μm and a spring constant of 31.9 pN/nm was used for these 
measurements. Prior to plating cells on the cross-linked collagen, the collagen was incubated 
overnight in 4 mL PBS containing 10 μg/mL human collagen at 37 °C.
2.8. Fabrication of collagen microwell scaffold on a modified Transwell insert
2.8.1. Microfabrication and surface modification of polydimethylsiloxane 
(PDMS) stamps—1002F photoresist was used to prepare a master mold for the PDMS 
stamps. 1002F was comprised of 1002F resin, photoinitiator (triarylsulfonium 
hexafluoroantimonate salts), and solvent (gamma-butyrolactone) as previously described 
[47]. The weight ratio of resin:photoinitiator:solvent was 65:6.5:28.5. A 500-μm thick film 
of 1002F was produced by spin-coating 1002F photoresist on a glass slide (75 mm × 50 mm 
× 1 mm). The film was baked at 95 °C for 60 min to evaporate the solvent, and was then 
exposed to UV light (1500 mJ/cm2) through an initial photomask with an array of 170-μm 
dark circles. A post-exposure baking step was next performed in a 95 °C oven for 10 min 
followed by baking on a 120 °C hotplate for 10 min. A second layer of 132-μm thick 1002 
photoresist was spin-coated onto the surface of the first resist layer. The film was exposed to 
UV light (1000 mJ/cm2) through a second photomask with an array of open circles 60 μm in 
diameter. The film was post-exposure baked as above and then developed with propylene 
glycol monomethyl ether acetate (PGMEA). The film was baked on a 120 °C hotplate for 60 
min to harden the film.
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PDMS stamp #1 was created from the above 1002F master mold by spreading PDMS pre-
polymer on the mold followed by de-gassing under a vacuum. PDMS on the mold was baked 
in a 95 °C oven for 30 min followed by demolding. PDMS stamp #1 contained an array of 
rounded-top posts for the villi alongside flat-bottomed microwells for the crypts. PDMS 
stamp #1 was treated with a plasma for 2 min, and coated with octyltrichlorosilane using a 
vapor-phase process for 16 h. A second PDMS stamp (stamp #2) was replicated in the same 
manner from stamp #1 to create a negative replica.
PDMS stamp #2 was trimmed to a size of 6 mm × 6 mm, and coated with poly(ethylene 
glycol) to eliminate collagen adhesion during molding. The PDMS stamps were surface-
grafted with poly(ethylene glycol) as described previously using UV-mediated graft 
polymerization [48]. Briefly, the PDMS stamps were placed in a glass tube with a screw-
cap. The tube was filled with a mixture of 10 wt% poly(ethylene glycol) methyl ether 
acrylate monomer, 0.5 mM sodium periodate, 0.5 wt% benzyl alcohol in water. The tube 
was then exposed to UV radiation in a Loctite 7411-S UV Flood System for 4 h. The stamps 
were then rinsed with deionized water and soaked in deionized water overnight to remove 
non-covalently bound polymer and monomer. The grafted stamps were stored in 75% 
ethanol until use.
2.8.2. Micromolding/cross-linking collagen scaffolds on a modified Transwell 
insert—A collagen scaffold was micromolded and cross-linked on the surface of a porous 
PTFE membrane (0.4 μm pore size) held in a 12-well insert. To construct the insert, the 
polycarbonate porous membrane was removed from a commercially available Transwell 
insert and a hydrophilic PTFE porous membrane was attached to the insert using a 
biocompatible transfer adhesive. To reduce the effective area of the porous membrane from 
12-mm to 3-mm in diameter, the backside of the membrane was partially sealed off by 
attaching a non-permeable COC plastic film of 200 μm thickness. This reduced the effective 
area of the porous membrane to 7.1 mm2. Next a mixture of 4 mg/mL collagen, 60 mM 
EDC and 15 mM NHS in MES buffer (0.1 M, pH 5) was prepared, and bubbles were 
removed by centrifugation at 3,000 × g for 1 min. The collagen mixture (50 μL) was added 
to the center of the modified insert, and PDMS stamp #2 was placed on the top of the 
mixture. To remove the trapped air bubbles amongst the microposts or inside microwells of 
the stamp, the 12-well plate was pressurized under 40 psi nitrogen for 2 h. The PDMS stamp 
was then removed from the collagen scaffold. The collagen scaffold was soaked in 2 liters of 
deionized water for 24 h with multiple water exchanges to remove unincorporated EDC and 
NHS [45, 49, 50]. Scaffolds were sterilized in 75% ethanol for 5 min, rinsed with PBS for 5 
min × 3, and stored in PBS at 4 °C until use. The total thickness of the collagen layer was 
~669 μm (477 μm-tall villi, 132 μm-deep crypts with a 60 μm-thick gel layer beneath the 
crypt well).
2.9. Generating crypt-villus architecture of human small intestinal epithelium 
by culturing cells on the collagen scaffold followed by imposition of a 
biochemical gradient—The modified Transwell insert enabled a diffusion-based gradient 
to be established across the collagen hydrogel and membrane when the upper and lower 
reservoirs were loaded with different media e.g. SM and DM media. The upper and lower 
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reservoirs were sufficiently large that they acted as an infinite sink and source over 24 h 
when the media was replaced every 24 h. To confirm that the lower (SM) and upper (DM) 
reservoirs acted as an infinite source and sink, PBS with fluorescein-dextran (100 μg/mL, 
MW=40,000, which is close to MW of Wnt-3A proteins) was added into the bottom or SM 
reservoir of the Transwell (with micromolded scaffold, but no cells). PBS alone was added 
into the top or DM reservoir. After 24 h, the concentration of fluorescein-dextran in the top 
or DM compartment was 4.0±1.0 μg/mL, and that in the bottom or SM reservoir was 
98.2±1.0 μg/mL (n=3). Thus, over the course of 24 h, the concentration of the reagents in the 
lower and upper reservoirs could be approximated as constant so that a stable, diffusion-
based gradient was formed across the collagen scaffold.
Just prior to use, the micromolded collagen scaffold was incubated overnight with 10 μg/mL 
human collagen in PBS at 37 °C. Cell fragments obtained from one well of neutralized 
collagen hydrogel in a 6-well plate were dispersed on four separate scaffolds housed within 
the modified Transwell inserts. The cells on the scaffold were cultured in 3 mL EM per 
insert (1 mL in the upper compartment, and 2 mL in the bottom compartment). The medium 
was exchanged every two days. Once the cells covered the entire surface of the scaffolds, 
typically 7 days, a gradient of growth factors was applied across the shaped collagen 
scaffold. DM (0.5 mL) was placed in the top compartment, and SM (1.5 mL) was loaded 
into the bottom compartment. The DM and SM were replenished daily.
2.10. EdU/ALP/Muc2/nuclei four-color staining protocol
Cell proliferation and differentiation were assessed with a four-color fluorescence staining 
protocol. Cells were incubated with 5-ethynyl-2-deoxyuridine (EdU, 10 μM) in medium for 
24 h at 37 °C. The living cells were washed in PBS and incubated for 30 min at 37 °C with 
alkaline phosphatase (ALP) substrate in Tris buffer (0.15 M, pH 8.4), rinsed with PBS, fixed 
in 4% paraformaldehyde for 15 min and then permeabilized with 0.5% Triton X-100 in PBS 
for 20 min. The proliferative cells were stained with a Click-iT EdU Alexa Fluor 647 
imaging kit. Subsequently, the cells were rinsed with 0.75% glycine in PBS for 5 min ×3, 
followed by blocking with 10% donkey serum for 1 h at 20 °C. Cells were then incubated in 
rabbit α-Muc2 (1:200) at 4 °C for overnight, and stained with donkey anti-rabbit IgG 
conjugated Alexa Fluor 488 (1:500) for 45 min at 20 °C. Nuclei were stained with Hoechst 
33342 (2 μg/mL) for 15 min at 20 °C.
2.11. Cryosection and immunofluorescence
Specimens were fixed in 4% paraformaldehyde for 15 min, rinsed with PBS, and incubated 
overnight in 30% sucrose at 4 °C. The tissue was then embedded in a cryo-embedding 
medium (OCT). The frozen tissue block was sectioned into 10-μm thick films with a 
cryostat. Primary antibodies used were against olfactomedin-4 (Olfm4) (1:500), cytokeratin 
20 (KRT20) (1:500), Muc2 (1:200), ezrin (1:200), villin (1:200), integrin β4 (1:200), and 
ZO-1 (1:200). Antigen retrieval was performed on specimens stained for Oflm4 and KRT20 
by incubating the sample in a antigen-retrieval solution at 95 °C for 15 min and then allowed 
to cool for 15 min. The sections were rinsed with PBS, and blocked with 10% donkey serum 
for 1 h at 20 °C. All sections were incubated with the primary antibody overnight at 4 °C 
followed by incubation with secondary antibody, donkey anti-rabbit or mouse IgG 
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conjugated with Alexa Fluor 488 or 594 (1:500). Nuclei were stained with Hoechst 33342 (2 
μg/mL) for 15 min. Alexa Fluor 488 phalloidin was used to stain filamentous actin (F-actin).
2.12. Image acquisition, analysis, and statistics
Specimens were imaged using a Nikon Eclipse TE300 inverted epifluorescence microscope 
equipped with DAPI/FITC/Texas Red/CY5 filter sets. Images were acquired at randomly 
selected locations with a 10× objective (N.A. = 0.3). S-phase cells stained with the Click-iT 
EdU stain were imaged using a CY5 filter (excitation filter 604–644 nm, emission 672–712 
nm), ALP stain was imaged employing a Texas Red filter (excitation filter 542–582 nm, 
emission 604–644 nm), Muc2 immunofluorescence was visualized with a fluorescein filter 
(excitation filter 450–490 nm, emission 520 nm long pass), and nuclei stained with Hoechst 
33342 was identified using a DAPI filter (excitation filter 352–402 nm, emission 417–477 
nm). Images were empirically thresholded using Image J (https://imagej.nih.gov/ij/). ImageJ 
was also used to measure the percent surface area of each image displaying supra-threshold 
fluorescence from the EdU, ALP or Muc2 stains. These areas were then normalized to the 
total cell area by dividing by the area of the Hoechst fluorescence (nuclei stain). Four 
randomly selected locations in the same monolayer were used to generate the image data 
and this experiment was repeated (n = 4). The average with a single standard deviation is 
shown unless otherwise specified. Statistical analysis was performed using a one-way 
analysis of variance (ANOVA) followed by a multiple comparison test with Tukey’s 
honestly significant difference procedure conducted at the 5% significance level. Multiple 
comparison testing was performed on all experimental groups. ANOVA analyses and 
subsequent multiple comparisons were performed using MATLAB (MATLAB 2014b, The 
MathWorks, Inc., Natick, Massachusetts). In all figures, ‘*’ denotes p < 0.05 and ‘**’ p < 
0.005.
To assess the polarity of the in vitro villus/crypt, the side view of the crypt/villus samples 
was obtained by scraping the tissue off the scaffold with a tungsten dissecting needle. 
Horizontally positioned crypts/villi were then imaged using standard fluorescence 
microscopy.
3. Results
3.1. Human small intestinal epithelium loses the crypt/villus architecture in the enteroid 
culture system
In vivo, human small intestinal epithelium demonstrates three prominent attributes: 
distinctive shaped crypts and villi, compartmentalization of cell types, and a luminal surface 
contacting the intestinal contents (Fig. 1A and B). The epithelium is comprised of an array 
of projections (villi) with interspersed invaginations (crypts). The villi are covered primarily 
with non-dividing differentiated (KRT20+) cells, while the majority of cells within the crypts 
are proliferative (Olfm4+) [51, 52]. The bases of the crypts host the stem cells within a 
supportive microenvironment or niche to maintain the stem cells in their undifferentiated 
state as well as to enable their proliferation to generate progenitors or transit amplifying 
cells to replenish the short-lived, differentiated cells. The terminally differentiated cells are 
preferentially located on the villi physically segregated from the stem/proliferative cells. 
Wang et al. Page 9
Biomaterials. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
When pre-isolated stem cells or crypts (with their stem cells) were cultured within a 
Matrigel patty, cell segregation was rapidly lost (Fig. 1A, C and D) [39]. The stem cells 
proliferated to form cystic structures, termed enteroids, possessing an enclosed lumen 
bordered by a single layer of epithelial cells (Fig. 1C). The enteroids were non-polarized and 
comprised predominantly of proliferative cells (EdU+, Olfm4+) with few differentiated cells 
(KRT20+) present (Fig. 1D). The proliferative cells were randomly intermixed with the few 
non-dividing, differentiated cells present. While the enteroid culture system has transformed 
the study of the small intestine, these enteroids bear little resemblance to the in vivo tissue 
and are unsuitable for study of many small intestine functions, such as stem cell 
compartment dynamics, cell migration and differentiation, chemical gradient influence, and 
microbiome interactions.
3.2. A cross-linked collagen hydrogel supports growth of human small intestinal cells as a 
proliferative monolayer undergoing differentiation in response to biochemical cues
We developed a cross-linked collagen hydrogel as a matrix to support the growth of human 
small intestinal cells as monolayers. Both carboxylic acid and primary amine groups are 
abundant in collagen [53]. In the presence of EDC and NHS, the carboxylic acid group of 
one chain of collagen is converted to a reactive NHS ester that subsequently reacts with a 
primary amine goup of the other chain of collagen to form a stable amide bond to covalently 
cross-link the collagen. During reaction, EDC/NHS acts to catalyze cross-linking and are not 
incorporated into the collagen, thus the EDC/NHS can be removed from the collagen gel 
after the reaction avoiding any negative impact on subsequent cell culture. The cross-linked 
collagen hydrogel possessed a modulus of 9.46±0.64 KPa (n=3). The cross-linked collagen 
possessed sufficient stiffness that the traction forces exerted by cells did not deform the 
collagen. To compensate for the possible loss of ECM contacts caused by cross-linking as 
well as the rat source of the collagen, the hydrogel was coated with a thin layer of human 
collagen prior to cell plating. Human small intestine fragments were cultured on the collagen 
surface in the presence of expansion medium (EM) for 4 days followed by stem medium 
(SM) for 4 days, which contained Wnt-3a, R-spondin 3, noggin and was optimized to 
support the proliferation of stem cells by activating Wnt signaling (Fig. 2A). The cells grew 
as a monolayer comprised predominantly of EdU+ proliferative cells with very few 
differentiated cells present as indicated by low or absent alkaline phosphatase (ALP) activity 
(or absorptive enterocytes) and mucin 2 (Muc2) immunostaining (or goblet cells) (Fig. 2B 
and C). The presence of cell consistent with stem cells (Olfm4+) were observed in the 
monolayer (Fig. 2D). The EDU+ and Olfm4+ cells (stem/proliferative cells) were distributed 
randomly throughout the monolayer so that a stem or proliferative cell compartment was not 
observed.
Since differentiated and stem cells co-exist in the epithelium of the native intestine, 
scaffolding for culture of small intestinal cells should support formation of differentiated 
cells in addition to stem cells. To determine whether the stem/proliferative cells grown as 
monolayers could be differentiated in a similar manner as those grown as enteroids [44], the 
monolayers were cultured in differentiation medium (DM) without growth factors. 
Differentiated cell markers (Muc2, ALP) increased indicating increased numbers of 
absorptive enterocytes and goblet cells. In contrast proliferation (EdU incorporation) 
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decreased relative to that of the control monolayers in SM suggesting a decline in the 
numbers of stem/proliferative cells under these conditions (Fig. 2B and C). In vivo cells of 
the small intestine are highly polarized with the luminal membrane surface and cytoplasm 
displaying proteins that participate in transport/absorption or its supporting infrastructure 
such as actin and ezrin which are at high concentration within the microvilli [54]. In 
contrast, other molecules such as integrin-β4 are localized to the basal membrane region 
providing interactions with the ECM underling the cells [55]. The differentiated monolayers 
on the collagen surface exhibited an appropriate basal-luminal polarity with actin and ezrin 
concentrated at the luminal surface (microvilli) and integrin-β4 at the basal surface. 
Mucin-2, a component of the intestinal mucous layer, lines the luminal surface protecting 
cells from digestive products and microbes [56]. In the monolayers, Muc2 was present only 
at the luminal cell surface indicating that mucous was secreted in the luminal direction only 
(Fig. 2D). Tight interconnections between cells formed by tight and adherens junctions 
block leakage of bile, microbes and other harmful entities into the underlying tissue [57]. 
The monolayers on collagen displayed properly localized β-catenin in the basolateral cell 
region and ZO-1 indicating the presence of adherens and tight junctions. These data 
demonstrate that monolayers were responsive to external cues in a manner similar to 
enteroids. More importantly, the proliferative monolayers differentiate into a fully polarized 
epithelial cell with key features of in vivo small intestinal cells.
Modulation of notch signaling is reported to alter proliferation and differentiation of 
intestinal epithelial stem cells in enteroids [58]. Gradients of a notch signaling activator and 
inhibitor were applied to the monolayer to determine whether the monolayers responded in a 
manner similar to that of enteroids. Gamma secretase inhibitors (GSI) diminish Notch 
signaling by blocking proteolytic activation of Notch receptors leading to differentiation of 
proliferative cells into goblet cells [59, 60]. For this reason, GSI (10 μM DAPT) was added 
to DM for culture of the monolayer. An increase in goblet cells (Muc2+) was not observed as 
in the enteroids, but formation of absorptive enterocytes (ALP+) was greatly increased 
relative to that of DM alone (Fig. 2B and C). Butyrate or short chain fatty acids are reported 
to act as Notch1 activator [61]. Addition of butyrate (5 mM) to DM did not significantly 
increase ALP or Muc2 expression relative to DM only. Butyrate also initiated rapid cell 
death in the small intestine epithelial cells probably due to its effect as a histone deacetylase 
(HDAC) inhibitor [62]. This effects of DAPT and a short chain fatty acid on the monolayers 
is different from that reported for enteroids [44], potentially due to addition of the molecules 
directly to the luminal surface of the monolayer rather than to the basal surface as occurs in 
the enteroid system.
3.3. The cross-linked collagen scaffold can be micromolded in the anatomical shape of the 
human small intestinal epithelium
PDMS stamps possessing the true (stamp #1) and reversed (stamp #2) architecture of the 
human small intestinal epithelium were fabricated through multiple steps including two-
layer photolithography and soft lithography replica molding (Fig. 3A). Microwells 
representing the negative of the villi were first patterned into an epoxy photoresist using 
standard spincoating and photo-illumination steps. In a similar fashion, a second layer of 
photoresist was patterned with micropillars or negatives of the crypts. To create the rounded 
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surfaces of the villi, a shortened rinse/development cycle was used for the photoresist master 
mold to leave a small amount of the resist at the bottom of the villi microwells. During the 
hard bake used to form the mold, the photoresist residue melted, reflowed and formed a 
meniscus inside the microwell creating a curved surface. The geometry of the 
microstructures (stamp #1) shown in Fig. 3B was designed to simulate the anatomical shape 
of the in vivo human duodenal epithelium (villus height = 437±98 μm, villus width = 
149±41 μm, crypt depth = 193±37 μm, mucosal thickness = 642±128 μm, and crypt to villus 
ratio= 2.26±0.57, n=10 [63]). On PDMS stamp (#1), the villus height = 477 μm, villus width 
= 170 μm, crypt depth = 132 μm, crypt width = 60 μm, total height of crypt/villus = 609 μm, 
and crypt to villus ratio = 2. After formation of the master mold in photoresist, two 
sequential rounds of soft lithography were used to form a PDMS replica of the master mold. 
The microscopic images of the PDMS stamps (#1) show six wells (for crypts) surrounding a 
single pillar (for villus) (Fig. 3C and D). The surface of PDMS stamps (#2) was covalently 
grafted with polyethylene glycol to eliminate collagen adhesion during molding.
To reproduce the surface topography of the small intestinal epithelium, PDMS stamp #2 was 
pressed into the surface of collagen overlaid onto the porous membrane in a modified 
Transwell insert (Fig. 3E). An array of rounded pillars (villi) and adjacent microwells 
(crypts) formed from in the cross-linked collagen as it gelled. Each villus/crypt array 
possessed approximately 90 pillars or villi structures and 180 microwells or crypt structures 
in the region above the porous membrane in contact with the basal reservoir below the 
modified insert (Fig. 3F). When viewed by brightfield microscopy, the villi were readily 
visualized as protruding above the surface while the much smaller crypts dipped below the 
plane of the epithelial surface (Fig. 3G). The shaped scaffolding in the modified insert was 
placed into a standard 12-well plate to create separate upper (luminal) and lower (basal) 
fluid reservoirs enabling distinct solutions to be applied to the upper and lower surfaces of 
the molded collagen.
3.4. Human small intestinal cells form a monolayer covering the shaped collagen scaffold
Cells were plated on the scaffolds and cultured under expansion medium (EM) in both the 
luminal and basal reservoirs (Fig. 4A). The crypt/villus surfaces were covered in a 
monolayer of cells within 9 days (Fig. 4B). On a randomly selected location (2.246 × 1.677 
mm), 79% of 108 crypts were observed to be lined with cells, and 100% of 56 villi were 
completely covered with cells. Ten arrays were fabricated all were successfully covered with 
a cell monolayer. As the cells grew to cover the scaffold surface, the cells were easily 
visualized as high-contrast darker regions rimming the inside of the crypts or outside of the 
villi (Fig. 4B). No multilayered cell regions were observed (see also Fig. 5 and 6). Adjusting 
the microscopy focal plane either upward or downward enabled visualization of cells within 
the crypt lumen or on the villus top surface (Fig. 4C and D). Crypts lined with cells 
possessed visible lumens (Fig. 4C). When pulsed with EdU, proliferative cells occupied the 
crypt walls as well as the majority of the villi surface. The EdU+ cells were randomly 
distributed across the array surface and suggested that the entire array crypt plus villus 
surfaces were covered with stem/proliferative cells. The created in vitro tissue possessed a 
crypt-villus architecture but without proper stem and differentiated cell segregation in the 
crypts and villi (Fig. 4D).
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3.5. Application of chemical gradients across the cell-covered scaffold creates stem/
proliferative and differentiated cell compartments
Human small intestinal cells were cultured on a scaffold until a confluent crypt-villus array 
was formed by visual inspection (typically 7 days). To polarize the in vitro crypt-villus 
architecture, a gradient of 3 growth factors (Wnt-3A, R-spondin 3 and noggin) was applied 
along the crypt-villus axis by placing DM in the luminal or upper fluid reservoir and SM in 
the basal or lower reservoir. Selection of the 3 factors for the gradient was based on prior 
work demonstrating that Wnt-3A and R-spondin activate the Wnt signaling pathway to 
support stem cells while Noggin inhibits BMP to block differentiation [44, 51, 52, 64]. Thus 
Wnt-3A, R-spondin and Noggin are all critical for stem cell maintenance but not for 
formation of the differentiated lineages particularly enterocytes. The DM and SM were 
replaced every 24 h so that the reservoirs acted as an infinite source and sink maintaining a 
linear gradient of 3 growth factors across the collagen scaffolding (Fig. 5A). After culture 
for 4 days under the gradient, a polarized tissue with proliferative cells (EdU+) confined to 
the crypts and adjacent regions, but absent from the villi, was formed (Fig. 5B and C). Thus 
a simple linear gradient of three factors was sufficient to create a proliferative (crypt) and 
non-proliferative (villus) compartment in the small intestinal construct (Fig. 5D). On the 
array possessing 90 cell-covered-villi and 127 cell-lined-crypts shown in Fig. 5D, 100% of 
villi possessed no EdU+ cells on their uppermost region while 96% of crypts were lined with 
EdU+ cells. These data suggested that a stem cell compartment might exist within the crypts. 
To determine whether the villi hosted differentiated cells as they do in vivo, the construct 
developed under the growth-factor gradient was stained for alkaline phosphatase (ALP) 
activity. Very few ALP+ cells were observed on the tissue indicating that the non-
proliferating villus cells were unable to differentiate under these conditions (Fig. 5B and C). 
Thus, a true differentiated cell compartment was not created by this 3-factor gradient. To 
generate a crypt-villus tissue with compartmentalized stem and differentiated cells, DAPT in 
DM was added to the luminal side while SM was placed in the basal reservoir (Fig. 5E). 
This bidirectional gradient localized the proliferative cells to crypts as before, but also 
induced the formation of absorptive enterocytes (ALP+) on the villi (Fig. 5F and G). ALP+ 
cells were not observed within the crypts. To define the location of the stem/proliferative 
cells, the constructs were sectioned and stained for Olfm4, a marker for stem and 
proliferative cells. Olfm4+ cells were confined to the crypts and adjacent regions (Fig. 5H) 
recapitulating the Olfm4 staining profile of primary tissue (Fig. 1B). KRT20 (human 
cytokeratin 20) marks terminally differentiated tissues of the intestine (Fig. 1B) and was 
localized to the villi tips in the in vitro small intestinal epithelium (Fig. 5H). KRT20 
immunostaining was absent from the crypts and adjacent regions. With respect to cell 
compartmentalization and architecture, the in vitro epithelium with crypts and villi displayed 
a marked resemblance in shape, polarity and luminal accessibility to that of in vivo tissue 
shown in Fig. 1B.
3.6. Proliferative cells in the crypts migrate upward into the villi over time
Directional migration of cells along the crypt/villus axis is an important in vivo renewal 
property of the intestinal epithelium. To maintain a homeostatic epithelial barrier, stem and 
progenitor cells proliferate and their offspring migrate up the villi to replenish the short lived 
differentiated cells that shed into the intestinal lumen [65]. To assess whether the in vitro 
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tissue construct recapitulated this in vivo movement of cells, the polarized tissue (4 days 
under gradient of growth factors) was labeled with EdU for 24 h. EdU was removed and the 
cells on the scaffold cultured for an additional 96 h under the gradient. At 0 h after EdU 
washout, the majority of EDU+ cells resided within the crypts and adjacent regions and 
EdU+ cells did not appear on the villi (Fig. 6A). At 96 h after removal of the EdU, EdU+ 
cells were readily observed along the length of the villi demonstrating that the EdU+ cells 
were migrating up the crypts and onto the villi (Fig. 6B). The migration of proliferative cells 
up the crypt-villus axis was quantified by measuring the distance that EdU+ cells moved 
during the 96 h after the EdU pulse (Fig. 6C). The cell migration rate was on average 40 μm/
day, which lies in the range of cell migration rates observed in animal experiments, e.g. 38–
63 μm/day for neonatal rat small intestine [66].
4. Discussion
Expansion of primary intestinal stem cells in vitro requires an appropriate biochemical and 
biophysical environment. Biochemically, a cocktail of soluble growth factors (mainly 
Wnt-3A, R-spondin and noggin) and small molecules are required to modulate cell signaling 
(Wnt, BMP) to promote stem cell maintenance and proliferation. A suitable matrix with 
proper ECM proteins and biophysical properties is required to act as a scaffolding for 
physical support of the cells. The enteroid culture system fulfills both requirements enabling 
expansion of human small intestinal stem cells in vitro [35]; however, the system yields 3D 
enteroids rather than the exposed 2D monolayer covering the intestinal surface probably due 
to the extremely low stiffness of the Matrigel (Young’s modulus = 50 Pa [67]).
To recapitulate the topography and cell behavior of the small intestinal epithelium as an 
organ-on-chip, a material other than Matrigel is needed to provide a suitably shaped 
scaffolding material. The material must: (1) have proper biophysical properties (stiffness, 
ECM contacts) to support monolayer formation with both stem and differentiated cells; (2) 
be sufficiently porous to allow diffusion of molecules through the matrix; (3) be compatible 
with a microfabrication process to generate microstructures; (4) maintain its integrity during 
long term culture of cells. Plastics and rubbers (e.g. polystyrene and PDMS) are 
impermeable to soluble molecules and possess high stiffness (Young’s modulus of 
polystyrene =3–3.5 GPa [68], PDMS = 0.8–4 MPa [69]). PDMS has been microfabricated 
into stretchable porous membranes for building a Caco-2 cell-based human gut-on-a-chip 
[15], but this device did not support long-term culture of primary human small intestinal 
cells [70]. A porous biodegradable poly(lactic-co-glycolic acid) (PLGA, stiffness = 1–2 GPa 
[71]) has been micromolded into high-aspect ratio pillars to allow growth and differentiation 
of enteroids [72], but support of stem cells was not demonstrated. Polystyrene and PDMS 
while coomon materials in fabrication of microdevices, do not possess the properties 
required for the self-renewal of intestinal stem cells.
Neutralized collagen hydrogel possesses a stiffness of 100–1,000 Pa (depending on collagen 
type and concentration) and has been identified to support both enteroid [73] and monolayer 
[74] formation of primary intestinal epithelial stem cells. The neutralized collagen hydrogel 
also supported the self-renewal of human small intestinal stem cells in 2D monolayers in this 
report. It is likely that the collagen hydrogel closely mimics the in vivo intestine’s basement 
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membrane in terms of porosity, ECM proteins and stiffness. While the collagen hydrogel 
supported human small intestinal stem cells as monolayers, this hydrogel is unsuitable for 
building 3D microstructured scaffolds due to its low strength. We attempted to micromold 
and shape a collagen hydrogel into high-aspect ratio microwells, but found that growth of 
the primary intestinal cells on the surface rapidly destroyed the scaffold eliminating the 
microstructures. This was likely due to the inability of the native collagen to resist the 
traction forces applied by cells on the matrix as well as collagen’s susceptibility to protease 
remodeling mediated by the cells [75]. The low strength of collagen hydrogel was addressed 
by chemically cross-linking the collagen. Collagen hydrogels, micromolded into high aspect 
ratio micropillars and then cross-linked with glutaraldehyde, supported the proliferation of 
Caco-2 cells without cell induced deformation [76]. Here we used a different method to 
cross-link collagen. An acidic solution of collagen was mixed with EDC and NHS to allow 
the cross-linking reaction to occur prior to fiber aggregation. The resulting collagen hydrogel 
is optically clear, possessing a stiffness of 9,460 Pa. Human small intestinal cells proliferated 
on the cross-linked collagen hydrogel and underwent forced differentiation when placed in 
the appropriate chemical environment. In addition, the cross-linked collagen was readily 
molded into microwells and micropillars to mimic the anatomical shape of the human small 
intestinal epithelium. Cell induced deformation of the scaffolding was not observed. The 
cross-linked collagen hydrogel is also porous enabling the establishment of a gradient across 
the scaffold to polarize the stem cells populated on its surface. Thus, the cross-linked 
collagen hydrogel act as an excellent scaffold for construction of an in vitro replica of the 
small intestinal epithelium from primary cells.
5. Conclusions
A cross-linked collagen hydrogel was identified as a suitable biomimetic scaffold to support 
in vitro culture of primary human small intestinal epithelial cells both as proliferative and 
differentiated cells, with differentiated cell formation responsive to external biochemical 
cues. The cross-linked collagen hydrogel was molded into micropillars and microwells to 
replicate the anatomical shape of the human small intestinal epithelium. Cells plated on the 
scaffolds were guided to form a crypt-villus architecture, which was then polarized by 
application of gradients of soluble biochemical reagents along the crypt-villus axis. The in 
vitro human small intestinal tissue mimicked the in vivo tissue in terms of architecture, 
tissue polarity and luminal accessibility. We expect this platform will serve as a 
physiologically relevant experimental mimic for studying the effect of nutrients, prebiotics, 
medicines, microbiota, and toxins on human small intestinal epithelium. The platform 
should find significant utility in translational studies, for example, in high-content screening 
of pharmaceuticals and microbiota therapeutics since the platform utilizes normal human 
tissue rather than mouse primary cells or human tumor cells. Finally, the use of human 
biopsy material enables construction of disease-specific mimics for the better understanding 
of human pathophysiology as well as disease amelioration.
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Appendix A. Supplementary data
Table S1. Supplier, catalog number, stock solution concentration, and storage condition of 
reagents
Table S2. Formulation of culture media for small intestinal epithelial cells
Wang et al. Page 20
Biomaterials. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
The enteroid culture system converts the highly structured in vivo crypt-villus architecture 
into non-polarized enteroids with an inaccessible lumen. (A) Schematic showing the 
isolation crypts from human small intestinal mucosa and their culture as enteroids. Stem and 
progenitor cells are green while differentiated cells are red. (B) Immunofluorescence 
staining of freshly obtained human small intestinal tissues showing that the epithelium is 
composed of an array of crypts/villi with differentiated cells (KRT20+) located along the 
villi while the stem and progenitor cells are confined within the crypts (Olfm4+). DNA 
(nuclei) was stained with Hoechst 33342. (C) Enteroid culture of human small intestine 
crypts by embedding in Matrigel. Shown are the structures on day 0, 1, and 2 of culture at 
passage number 0 and 1. (D) EdU and immunofluorescence staining of human enteroids 
after 4 days in culture. Scale bar = 100 μm.
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Fig. 2. 
Monolayer culture of human small intestinal cells on a cross-linked collagen hydrogel. (A) 
Schematic of the culture of cells on the cross-linked collagen followed by forced 
differentiation of the cells. (B) Cells were cultured in expansion medium (EM, 4 days) and 
then either stem medium (SM) or differentiation medium (DM) for 4 days. Additional 
reagents added to the differentiation media 5 mM butyrate (DM-B) or 10 μM DAPT (DM-
D). Colors as follows: EdU, green; ALP, red; Muc2, yellow; DNA, blue. (C) The percentage 
of the monolayer surface area displaying fluorescence from the EdU, Muc2, and ALP stains 
under the various culture conditions. (D) Monolayer side view of Oflm4 (SM), integrin-β4 
and actin (DM), ezrin (DM), Muc2 (DM), β-catenin and actin (DM), and top view of ZO-1 
(DM). DNA (nuclei) was stained with Hoechst 33342.
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Fig. 3. 
Micromolding a collagen scaffold on a porous membrane. (A) Schematic of the process used 
to generate the PDMS stamp to micromold the collagen. (B) The dimensions of 
microstructures in stamp #1 which replicate the features formed in the collagen. The units 
for the numbers are in μm. (C) A top view of stamp #1 is shown using brightfield 
microscopy. (D) A side view of stamp #1 is shown using electron microscopy. (E) Schematic 
of micromolded collagen in the modified insert. (F) Top views of the shaped collagen array 
acquired by brightfield microscopy. (G) A close-up view.
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Fig. 4. 
Culture of human small intestinal cells on a collagen scaffold recreates in vitro crypt-villus 
architecture. (A) Schematic of cell propagation on the microstructures. (B) Cells cultured on 
a scaffold were tracked by brightfield microscopy over time as the cells spread across the 
scaffold surface. (C) A brightfield image with the focal plane at the level of the crypt 
showing that cells migrated into the microwell. (D) An image with the focal plane at the top 
of the villus showing cells migrated to the top of the micropillar. (E) Fluorescence side view 
image of the crypt-villus architecture displaying one villus and two crypt structures from an 
EdU-pulsed array.
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Fig. 5. 
Creating a polarized tissue by applying gradients to the in vitro crypt-villus arrays. (A) 
Schematic of the gradient of growth factors (W: Wnt-3A; R: R-spondin 3; N: noggin). 
Brightfield (B) and fluorescence (C) images of a polarized crypt-villus unit under the 3-
growth factor gradient. EdU+ cells (green) are confined to the crypt and adjacent regions, 
while no ALP+ cells (red) are observed. DNA or nuclei are shown in blue. (D) A wide field 
view of the polarized crypt-villus epithelium array (3 mm in diameter) under the 3-growth 
factor gradient. (E) Schematic showing the application of an additional gradient comprised 
of DAPT (gamma secretase inhibitor). Brightfield (F) and fluorescence (G) images of a 
polarized crypt-villus unit under the 3-growth factor gradient and opposing DAPT gradient. 
Mature enterocytes (red, ALP+) and proliferative cells (green, EdU+) are also marked. (H) 
Immunofluorescence staining (Olfm4/KRT20) of in vitro human small intestinal tissues 
showing tissue polarity under the combine growth factor and DAPT gradient. Scale bar = 
100 μm for B,C,F,G,H.
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Fig. 6. 
Cell migration up the crypt-villus axis of the in vitro tissue over time. Tissues were fixed at 0 
(A) and 96 (B) h post-EdU pulse (24-h EdU pulse duration), and the incorporated EdU was 
labeled with an EdU-reactive Alex Fluor dye (green). DNA or nuclei were stained with 
Hoechst 33342 (blue) (C) Box plots of the relative proliferation length which was defined as 
the length of EdU+ tissue divided by the cypt + villus length (659 μm) at 0 and 96 h post-
EdU pulse. 26 (0 h) and 20 (96 h) crypt-villus units were quantified. p<0.0001 based on t-
test. Scale bar = 100 μm
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